Amneal 制药 AMRX
$20.14 +$0.69 (+3.55%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.14 0.00%
开盘$19.45
昨收$19.45
当日区间$19.30 – $20.43
成交量4.73M
市值$6.43B
市盈率（TTM）50.4
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$796.20M+9.9% YoY
营业利润$145.98M+30.3% YoY
净利润$69.61M+95.5% YoY
摊薄每股收益$0.18+157.1% YoY
自由现金流-$143.99M-355.2% YoY
经营现金流-$21.24M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率39.3%
营业利润率15.4%
净利率5.0%
资产收益率4.4%
流动比率2.20
负债/资产比率99.1%
现金及投资$127.64M
总负债$2.78B
净现金（净负债）-$2.65B
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $796.20M | $722.52M | $3.02B | $814.32M | $784.51M |
| 营业总收入 | $796.20M | $722.52M | $3.02B | $814.32M | $784.51M |
| 营业成本 | $461.69M | $402.41M | $1.91B | $517.13M | $510.54M |
| 毛利润 | $334.51M | $320.11M | $1.11B | $297.19M | $273.97M |
| 营业费用 | $188.53M | $171.84M | $715.39M | $182.69M | $203.49M |
| 销售及管理费用 | $148.72M | $138.86M | $526.83M | $146.46M | $137.82M |
| 研发费用 | $41.10M | $39.93M | $193.81M | $36.23M | $65.79M |
| 其他营业费用 | -$1.30M | -$6.94M | -$5.24M | -$1,000.00 | -$117,000.00 |
| 营业利润 | $145.98M | $148.27M | $397.91M | $114.50M | $70.49M |
| 非经营性利息净收入（支出） | -$55.04M | -$56.87M | -$272.46M | -$56.24M | -$94.18M |
| 非经营性利息支出 | $55.04M | $53.36M | $241.09M | $56.24M | $62.81M |
| 其他收入（支出） | -$19.95M | -$11.22M | $13.75M | -$3.03M | $18.47M |
| 证券出售收益 | -$1.95M | -$7.80M | $7.64M | -$1.44M | -$3.43M |
| 特殊收益（费用） | -$18.65M | -$4.16M | -$10.41M | -$14.76M | $20.67M |
| -减：重组及并购费用 | $8.15M | $5.80M | $4.21M | $2.47M | $143,000.00 |
| -减：其他特殊支出 | $10.50M | -$1.64M | $6.20M | $12.29M | -$20.81M |
| 其他非经营性收入（支出） | $653,000.00 | $742,000.00 | $16.52M | $13.17M | $1.24M |
| 税前利润 | $70.99M | $80.18M | $139.21M | $55.24M | -$5.22M |
| 税费 | $1.38M | $2.18M | $11.28M | $5.66M | -$23.36M |
| 净利润 | $69.61M | $78.00M | $127.93M | $49.57M | $18.13M |
| 持续经营利润 | $69.61M | $78.00M | $127.93M | $49.57M | $18.13M |
| 少数股东权益 | $11.95M | $15.74M | $55.88M | $14.50M | $15.76M |
| 归属母公司净利润 | $57.66M | $62.26M | $72.06M | $35.08M | $2.37M |
| 归属普通股股东净利润 | $57.66M | $62.26M | $72.06M | $35.08M | $2.37M |
| 基本每股收益 | $0.18 | $0.20 | $0.23 | $0.11 | $0.01 |
| 摊薄每股收益 | $0.18 | $0.19 | $0.22 | $0.11 | $0.01 |
| 其他财务成本合计 | – | $3.51M | $31.37M | $0.00 | $31.37M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $3.78B | $3.54B | $3.68B | $3.68B | $3.60B |
| 流动资产合计 | $1.95B | $1.80B | $1.91B | $1.91B | $1.84B |
| 现金及现金等价物与短期投资 | $127.64M | $197.66M | $282.03M | $282.03M | $201.25M |
| -现金及现金等价物 | $127.64M | $197.66M | $282.03M | $282.03M | $201.25M |
| 应收款 | $1.08B | $902.65M | $939.87M | $939.87M | $924.14M |
| -应收账款 | $1.02B | $850.86M | $895.14M | $895.14M | $885.20M |
| -应收税款 | $19.38M | $20.01M | $18.66M | $18.66M | $15.78M |
| -一年内应收关联方款项 | $424,000.00 | $508,000.00 | $470,000.00 | $470,000.00 | $1.29M |
| -其他应收款 | $42.47M | $31.28M | $25.60M | $25.60M | $21.87M |
| 预付资产 | $50.17M | $51.81M | $54.13M | $54.13M | $63.87M |
| 存货 | $677.95M | $641.62M | $606.30M | $606.30M | $614.50M |
| 受限现金 | $8.64M | $4.17M | $28.84M | $28.84M | $34.73M |
| 非流动资产合计 | $1.83B | $1.74B | $1.77B | $1.77B | $1.76B |
| 固定资产净值 | $609.92M | $558.76M | $550.33M | $550.33M | $538.06M |
| -固定资产原值 | $609.92M | $558.76M | $1.16B | $1.16B | $538.06M |
| 金融资产 | $16.21M | $10.15M | $5.76M | $5.76M | $5.17M |
| 一年以上预付资产 | $6.11M | $32.01M | $37.55M | $37.55M | $16.91M |
| 商誉及其他无形资产 | $1.18B | $1.13B | $1.16B | $1.16B | $1.18B |
| -商誉 | $593.50M | $593.80M | $595.47M | $595.47M | $595.95M |
| -其他无形资产 | $587.83M | $534.87M | $563.50M | $563.50M | $587.94M |
| 一年以上递延资产 | $4.62M | $4.91M | $5.20M | $5.20M | $5.49M |
| 其他非流动资产 | $11.13M | $7.81M | $9.31M | $9.31M | $11.89M |
| 负债合计 | $3.74B | $3.59B | $3.75B | $3.75B | $3.71B |
| 流动负债合计 | $883.19M | $728.05M | $881.63M | $881.63M | $862.11M |
| 应付款 | $266.30M | $260.71M | $310.16M | $310.16M | $344.80M |
| -应付账款 | $244.23M | $227.68M | $254.67M | $254.67M | $266.36M |
| -一年内应付关联方款项 | $22.07M | $33.04M | $55.49M | $55.49M | $68.21M |
| 一年内应计费用 | $407.30M | $381.03M | $426.76M | $426.76M | $391.34M |
| 短期债务及融资租赁负债 | $121.42M | $21.49M | $21.58M | $21.58M | $21.47M |
| -一年内到期债务 | $105.96M | $6.20M | $6.76M | $6.76M | $7.20M |
| -一年内到期融资租赁负债 | $15.46M | $15.29M | $14.82M | $14.82M | $14.27M |
| 其他流动负债 | $18.49M | $10.55M | $43.26M | $43.26M | $40.60M |
| 非流动负债合计 | $2.86B | $2.86B | $2.87B | $2.87B | $2.85B |
| 长期应付账款及其他应付款 | $0.00 | $0.00 | $0.00 | $0.00 | $216,000.00 |
| 长期债务及融资租赁负债 | $2.67B | $2.68B | $2.67B | $2.67B | $2.66B |
| -长期债务 | $2.56B | $2.57B | $2.57B | $2.57B | $2.57B |
| -长期融资租赁负债 | $106.01M | $109.44M | $102.36M | $102.36M | $97.75M |
| 一年以上应付关联方款项 | $2.89M | $456,000.00 | $19.13M | $19.13M | $8.59M |
| 一年以上递延负债 | $22.04M | $14.66M | – | – | – |
| 员工福利 | $8.91M | $10.85M | $11.35M | $11.35M | $18.35M |
| 可转换优先证券 | $83.96M | $85.91M | $77.29M | $77.29M | $67.78M |
| 其他非流动负债 | $72.00M | $71.25M | $92.73M | $92.73M | $88.53M |
| 股东权益合计 | $33.02M | -$45.97M | -$71.33M | -$71.33M | -$109.96M |
| 股东权益 | $33.02M | -$45.41M | -$70.79M | -$70.79M | -$109.46M |
| 股本 | $3.19M | $3.19M | $3.15M | $3.15M | $3.14M |
| -普通股 | $3.19M | $3.19M | $3.15M | $3.15M | $3.14M |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $545.58M | $536.30M | $571.79M | $571.79M | $563.36M |
| 留存收益 | -$415.09M | -$472.75M | -$535.01M | -$535.01M | -$570.08M |
| 不影响留存收益的损益 | -$100.67M | -$112.15M | -$110.73M | -$110.73M | -$105.88M |
| 少数股东权益 | $0.00 | -$558,000.00 | -$535,000.00 | -$535,000.00 | -$497,000.00 |
| -累计折旧 | – | – | -$606.17M | -$606.17M | – |
| -其他应付款 | – | – | – | – | $10.23M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$21.24M | -$26.74M | $339.99M | $130.32M | $118.45M |
| 持续经营经营活动现金流净额 | -$21.24M | -$26.74M | $339.99M | $130.32M | $118.45M |
| 持续经营净利润 | $69.61M | $78.00M | $127.93M | $49.57M | $18.13M |
| 持续经营损益 | $2.28M | $8.22M | -$7.45M | $1.15M | $3.21M |
| 折旧、折耗与摊销 | $47.80M | $43.19M | $223.57M | $49.23M | $54.07M |
| 其他非现金项目 | $8.57M | $11.76M | $59.76M | $7.81M | $41.88M |
| 营运资金变动 | -$191.51M | -$190.08M | -$204.52M | -$12.29M | -$50.74M |
| -应收款变动 | -$169.70M | $43.96M | -$120.58M | -$9.52M | -$77.34M |
| -存货变动 | -$69.19M | -$54.96M | -$87.03M | -$20.18M | -$30.81M |
| -预付资产变动 | -$10.75M | -$13.40M | -$19.16M | $1.01M | -$10.16M |
| -应付账款及应计费用变动 | $58.13M | -$165.68M | $22.25M | $16.40M | $67.56M |
| 投资活动现金流净额 | -$122.74M | -$21.71M | -$112.26M | -$45.45M | -$22.46M |
| 持续经营投资活动现金流净额 | -$122.74M | -$21.71M | -$112.26M | -$45.45M | -$22.46M |
| 固定资产购置及出售净额 | -$45.59M | -$13.86M | -$96.75M | -$42.45M | -$15.05M |
| 无形资产购置及出售净额 | -$77.15M | -$7.85M | -$15.51M | -$3.00M | -$7.41M |
| 筹资活动现金流 | $79.36M | -$59.06M | -$31.53M | -$10.12M | $59.44M |
| 持续经营筹资活动现金流净额 | $79.36M | -$59.06M | -$31.53M | -$10.12M | $59.44M |
| 债务发行及偿还净额 | $93.82M | -$6.17M | $101.24M | -$6.12M | $140.44M |
| 股票期权行使所得 | $42,000.00 | $38,000.00 | $1.96M | $553,000.00 | $653,000.00 |
| 其他筹资费用净额 | -$14.50M | -$52.92M | -$134.73M | -$4.55M | -$81.65M |
| 期末现金余额 | $139.62M | $204.41M | $312.94M | $312.94M | $238.41M |
| 现金净变动 | -$64.63M | -$107.51M | $196.20M | $74.74M | $155.43M |
| 期初现金余额 | $204.41M | $312.94M | $118.42M | $238.41M | $83.67M |
| 汇率变动影响 | -$164,000.00 | -$1.02M | -$1.68M | -$209,000.00 | -$694,000.00 |
| 自由现金流 | -$143.99M | -$48.45M | $225.64M | $84.15M | $95.99M |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 AMRX。
登录后参与讨论。